| Parathyroid carcinoma: incidence, survival analysis, and management: a study from the SEER database and insights into future therapeutic perspectives A Ullah, J Khan, A Waheed, N Sharma, EK Pryor, TR Stumpe, ... Cancers 14 (6), 1426, 2022 | 34 | 2022 |
| Multidisciplinary rounds in prevention of 30-day readmissions and decreasing length of stay in heart failure patients: A community hospital based retrospective study R Chava, N Karki, K Ketlogetswe, T Ayala Medicine 98 (27), e16233, 2019 | 30 | 2019 |
| Dysmenorrhea and stress among the nepalese medical students PC Katwal, NR Karki, P Sharma, SR Tamrakar Kathmandu Univ Med J 14 (56), 318-21, 2016 | 26 | 2016 |
| P-selectin blockade in the treatment of painful vaso-occlusive crises in sickle cell disease: a spotlight on crizanlizumab NR Karki, A Kutlar Journal of Pain Research, 849-856, 2021 | 22 | 2021 |
| Gastrointestinal stromal tumors (GIST): a population-based study using the SEER database, including management and recent advances in targeted therapy J Khan, A Ullah, A Waheed, NR Karki, N Adhikari, L Vemavarapu, ... Cancers 14 (15), 3689, 2022 | 21 | 2022 |
| Single total dose infusion of ferumoxytol (1020 mg in 30 minutes) is an improved method of administration of intravenous iron NR Karki, M Auerbach American Journal of Hematology 94 (9), E229-E231, 2019 | 20 | 2019 |
| Incidence, survival analysis and future perspective of primary peritoneal mesothelioma (PPM): a population-based study from SEER database A Ullah, A Waheed, J Khan, A Mishra, B Tareen, N Nama, NR Karki, ... Cancers 14 (4), 942, 2022 | 15 | 2022 |
| PD-L1 over-expression varies in different subtypes of lung cancer: will this affect future therapies? A Ullah, S Pulliam, NR Karki, J Khan, S Jogezai, S Sultan, L Muhammad, ... Clinics and Practice 12 (5), 653-671, 2022 | 14 | 2022 |
| A critical evaluation of crizanlizumab for the treatment of sickle cell disease NR Karki, K Saunders, A Kutlar Expert Review of Hematology 15 (1), 5-13, 2022 | 7 | 2022 |
| DIAPH1 mutation as a novel cause of autosomal dominant macrothrombocytopenia and hearing loss NR Karki, G Ajebo, N Savage, A Kutlar Acta Haematologica 144 (1), 91-94, 2021 | 5 | 2021 |
| Chordoma: demographics and survival analysis with a focus on racial disparities and the role of surgery, a US population-based study A Ullah, GS Kenol, KT Lee, AQK Yasinzai, A Waheed, B Asif, I Khan, ... Clinical and Translational Oncology 26 (1), 109-118, 2024 | 4 | 2024 |
| Clinicopathological and treatment patterns of combined small-cell lung carcinoma with future insight to treatment: a population-based study A Ullah, O Saeed, NR Karki, M Goodbee, AQK Yasinzai, A Waheed, ... Journal of clinical medicine 12 (3), 991, 2023 | 4 | 2023 |
| Mucoepidermoid carcinoma of the salivary gland: demographics and comparative analysis in US children and adults with future perspective of management A Ullah, J Khan, A Waheed, NR Karki, M Goodbee, AQK Yasinzai, ... Cancers 15 (1), 250, 2022 | 4 | 2022 |
| Pancreatic diffuse large B-cell lymphoma in the US population A Ullah, KT Lee, K Malham, AQK Yasinzai, B Tareen, D Lopes, A Wali, ... Cureus 15 (6), 2023 | 3 | 2023 |
| The care of the leukemic patients in times of SARS-CoV-2 NR Karki, T Le, J Cortes Current Oncology Reports 23, 1-13, 2021 | 3 | 2021 |
| Leukaemic relapse of anaplastic large cell lymphoma, ALK negative NR Karki, K Badin, N Savage, L Bryan BMJ Case Reports CP 14 (2), e239213, 2021 | 3 | 2021 |
| Indolent T-lymphoblastic proliferation in idiopathic multicentric castleman disease NR Karki, AS Arfa, N Savage, A Kutlar Acta Haematologica 145 (2), 214-220, 2022 | 2 | 2022 |
| A phase II trial of pembrolizumab and poly-ICLC in patients with metastatic mismatch repair-proficient colon cancer. NR Karki, K Bano, S Ramses, A Nayak Journal of Clinical Oncology 39 (15_suppl), e15552-e15552, 2021 | 2 | 2021 |
| Novel germline RUNX1 mutation associated with familial thrombocytopenia as well as B-acute lymphoblastic leukemia: a case report and review of the literature N Karki, N Savage, A Kutlar Case Reports in Oncology 14 (1), 439-445, 2021 | 2 | 2021 |
| Comprehensive molecular profiling of paired patient samples of primary and metastatic (met) pancreatic ductal adenocarcinoma (PDAC). N Trivedi, R Feldman, H Wang, NR Karki, J Marshall, BA Weinberg Journal of Clinical Oncology 36 (15_suppl), 4114-4114, 2018 | 2 | 2018 |
